Global Magnetic Resonance Imaging Devices Market to reach USD 13,553.33 million by 2032 at a CAGR of 6.54% by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The growing incidence of chronic illnesses-including heart disease, cancer, and neurological disorders is driving demand for advanced diagnostic methods such as MRI, which provides highly detailed imaging of soft tissues and internal organs. Increasing awareness and a stronger focus on early disease detection are also prompting both patients and healthcare professionals to rely on MRI for faster and more accurate diagnosis. In addition, ongoing technological progress such as the development of high-field scanners, open MRI systems, functional MRI (fMRI), and faster imaging techniques is enhancing scan precision, patient comfort, and overall efficiency. Together, these factors are expected to significantly boost the global need for magnetic resonance imaging devices throughout the 2025-2032 forecast period.

DelveInsight's "Magnetic Resonance Imaging Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Magnetic Resonance Imaging Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Magnetic Resonance Imaging Devices market, get a snapshot of the report Magnetic Resonance Imaging Devices Market Trends
https://www.delveinsight.com/sample-request/magnetic-resonance-imaging-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Magnetic Resonance Imaging Devices Overview
Magnetic Resonance Imaging (MRI) devices are advanced medical imaging systems that use strong magnetic fields and radio waves to create detailed, cross-sectional images of organs, tissues, and other internal structures of the body. Unlike X-rays or CT scans, MRI does not use ionizing radiation, making it a safer option for many patients.
MRI devices are widely used for diagnosing conditions related to the brain, spine, joints, heart, blood vessels, and soft tissues. They help physicians detect abnormalities such as tumors, neurological disorders, injuries, and infections with high accuracy and clarity.

DelveInsight Analysis: The magnetic resonance imaging (MRI) devices market size was worth USD 8,207.06 million in 2024 and is expected to grow at a CAGR of 6.54% between 2025 and 2032, reaching approximately USD 13,553.33 million by 2032.

Magnetic Resonance Imaging Devices Market Insights
Geographically, North America is expected to lead the global magnetic resonance imaging (MRI) devices market in 2024. This strong market position is driven by a growing burden of conditions such as neurological disorders, cardiovascular diseases, and cancer, along with continuous technological innovation, supportive government policies, and the active involvement of major industry players in strategic developments across the region.

To read more about the latest highlights related to Magnetic Resonance Imaging Devices, get a snapshot of the key highlights entailed in the Magnetic Resonance Imaging Devices Insights
https://www.delveinsight.com/report-store/magnetic-resonance-imaging-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Magnetic Resonance Imaging Devices Market Report
• In September 2025, Ascelia Pharma submitted a New Drug Application to the FDA for Orviglance®, seeking approval as a liver MRI contrast agent for patients with severe kidney impairment, supported by nine clinical studies showing positive safety and efficacy.
• In September 2025, Tempus AI (NASDAQ: TEM) received FDA 510(k) clearance for its updated Tempus Pixel, an AI-powered cardiac imaging platform. The update adds T1 and T2 inline map generation, enhancing cardiac MRI image analysis capabilities.
• In Sept 2025, ClearPoint Neuro's ClearPoint Prism® Neuro Laser Therapy System received FDA 510(k) clearance to add 1.5T MRI guidance alongside the existing 3T MRI. This expansion boosts the device's market potential in the U.S., where 1.5T MRIs make up about 60% of clinical use, and globally, where they represent over 70% of installed MRI systems.
• In July 2025, the FDA granted 510(k) clearance for Philips' SmartSpeed Precise deep learning reconstruction software. This AI-driven tool enables up to three times faster MRI scans and produces images 80% sharper, enhancing diagnostics in cardiology, oncology, and neurology.
• In June 2025, Hyperfine, Inc. (Nasdaq: HYPR) announced FDA clearance for its next-generation portable MRI scanner featuring proprietary Optive AITM software, delivering its highest image quality and usability yet-advancing brain imaging for clinicians and patients.
• In June 2025, Polarean Imaging announced FDA approval of its Supplemental NDA for XENOVIEW®, lowering the minimum patient age from 12 to six years, expanding access and its total addressable market.
• In May 2025, Hyperfine (Nasdaq: HYPR) announced FDA clearance of its next-generation software for the Swoop® portable MRI system, significantly enhancing image quality for ultra-low-field brain imaging.
• In February 2025, Prenuvo, the leader in proactive whole-body MRI screening, disclosed raising $120M in Series B funding, underscoring its leadership in preventative health. The company has identified over 1.4 million personalized health insights across its member base, emphasizing the importance of early detection.
• In February 2025, Subtle Medical, the global leader in AI-powered medical imaging enhancement, announced FDA clearance for Subtle-HDTM, the most advanced MRI acceleration and enhancement software to date.
• In February 2025, Ezra, the healthcare AI startup focused on early cancer detection through full-body MRI screening, announced that its advanced Ezra Flash AI model received 510(k) clearance from the U.S. FDA.
• In July 2024, FUJIFILM Healthcare Americas Corporation announced the U.S. launch of the APERTO LucentTM, a high-performance open 0.4T MRI system. Leveraging Fujifilm's advanced permanent magnet technology, the system features a unique single-pillar design and a wide, laterally moving table, enhancing patient accessibility and comfort. Its open architecture caters to patients with claustrophobia and facilitates a more relaxed imaging experience without compromising image quality.
• Thus, owing to such developments in the market, rapid growth will be observed in the Magnetic Resonance Imaging Devices market during the forecast period

Key Players in the Magnetic Resonance Imaging Devices Market
Some of the key market players operating in the Magnetic Resonance Imaging Devices market include- General Electric Company, FUJIFILM Holdings Corporation, Siemens Healthcare GmbH, Koninklijke Philips N.V., Canon Medical Systems Corporation, ESAOTE SPA, Aspect Imaging Ltd., Bruker Corporation, Aurora Healthcare US Corp., FONAR Corp., Neusoft Medical Systems Co., Ltd., Shenzhen Anke High-Tech Co. Ltd., Shenzhen Basda Medical Apparatus Co. Ltd., Time Medical Holding, Hyperfine, Alltech Medical Systems, InnerVision MRI Ltd., Magnetica Limited, IMRIS, Deerfield Imaging, Inc., and others.

Which MedTech key players in the Magnetic Resonance Imaging Devices market are set to emerge as the trendsetter explore @ Key Magnetic Resonance Imaging Devices Companies
https://www.delveinsight.com/sample-request/magnetic-resonance-imaging-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Magnetic Resonance Imaging Devices Market Landscape
Technological progress is playing a key role in the growth of the high-field MRI systems market. New developments such as faster scanning sequences, improved motion-correction features, and AI-based image reconstruction are enhancing image clarity while shortening scan duration and minimizing patient discomfort. The introduction of open high-field MRI designs has also helped overcome issues like claustrophobia, making MRI more accessible for children, elderly individuals, and patients with obesity.
However, the market still faces obstacles, including the high cost of MRI equipment, complex installation requirements, and stringent regulatory standards for device approval. Even so, the rising need for non-invasive diagnostic imaging, combined with continuous advancements aimed at boosting patient comfort and workflow efficiency, is expected to drive strong revenue growth and support the expansion of the global high-field MRI devices segment over the forecast period.

Scope of the Magnetic Resonance Imaging Devices Market Report
• Coverage: Global
• Study Period: 2022-2032
• Magnetic Resonance Imaging Devices Market Segmentation By Field Strength: High-Field MRI Systems (1.5t to 3t), Low-to-Mid-Field MRI Systems (

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.